(RTTNews) - ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company focused on allergic reaction therapies, announced on Tuesday its participation in the 2025 American Academy of Allergy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback